ENTA - Enanta Pharma GAAP EPS of -$1.48 misses by $0.37 revenue of $27.65M beats by $0.28M February, 08 2022 04:03 PM Enanta Pharmaceuticals Inc. Enanta Pharma press release (NASDAQ:ENTA): Q1 GAAP EPS of -$1.48 misses by $0.37. Revenue of $27.65M (-12.9% Y/Y) beats by $0.28M. For further details see: Enanta Pharma GAAP EPS of -$1.48 misses by $0.37, revenue of $27.65M beats by $0.28M